TH129939B - Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL). - Google Patents

Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL).

Info

Publication number
TH129939B
TH129939B TH1201005970A TH1201005970A TH129939B TH 129939 B TH129939 B TH 129939B TH 1201005970 A TH1201005970 A TH 1201005970A TH 1201005970 A TH1201005970 A TH 1201005970A TH 129939 B TH129939 B TH 129939B
Authority
TH
Thailand
Prior art keywords
clevudine
adefovir dipivoxil
treatment
composition
chronic hepatitis
Prior art date
Application number
TH1201005970A
Other languages
Thai (th)
Other versions
TH129939A (en
Inventor
นายยัง-ชูน ลี นายซุง-กู ลี
Original Assignee
บุกวาง ฟาร์ม โคแอลทีดี
Filing date
Publication date
Application filed by บุกวาง ฟาร์ม โคแอลทีดี filed Critical บุกวาง ฟาร์ม โคแอลทีดี
Publication of TH129939A publication Critical patent/TH129939A/en
Publication of TH129939B publication Critical patent/TH129939B/en

Links

TH1201005970A 2011-04-18 Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL). TH129939B (en)

Publications (2)

Publication Number Publication Date
TH129939A TH129939A (en) 2013-11-28
TH129939B true TH129939B (en) 2013-11-28

Family

ID=

Similar Documents

Publication Publication Date Title
HK1248120A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
SMT201600476B (en) TENOFOVIR ALAFENAMMIDE EMIFUMARATE
IL231591A0 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
BR112015001838A2 (en) efflux inhibitor compositions and treatment methods using the same.
PL2888241T3 (en) 2,4,5,6-Substituted 3,6-dihydropyrimidine derivatives as hepatitis B virus (HBV) polymerase inhibitors for the treatment of e.g. chronic hepatitis
BR112014000653A2 (en) bruton tyrosine kinase inhibitors
DK3520805T3 (en) COMPOSITIONS FOR THE TREATMENT OF MYELOFIBROSE
BR112013029620A2 (en) bruton tyrosine kinase inhibitors
CL2015001088A1 (en) Process of elaboration of compounds derived from pyrimidine (div. Sol. 850-13).
CO6811873A2 (en) Parasiticidal Dihydroisoxazole Compound
DK3124610T3 (en) HBV TREATMENT
DK2741763T3 (en) COMPOSITION FOR CONTROLLED OVARI STIMULATION.
DK2846827T3 (en) BIOFILESES INTEGRATION WITH PLYSS2 LYSIN
BR112015004230A2 (en) inhaler.
WO2012166626A8 (en) Reagents and methods for treating dental disease
CL2014000849A1 (en) Compounds derived from substituted benzylindazoles, bub1 kinase inhibitors; manufacturing procedure; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of hyperproliferative diseases.
BR112015005361A2 (en) bruton tyrosine kinase inhibitors
BR112013032839A2 (en) zero emission dialysis clinic
EP3038626A4 (en) Cyclosporin analogues for preventing or treating hepatitis c
BR112013030897A2 (en) composition.
CL2014002817A1 (en) Anamorelin monohydrochloride compound that has controlled chloride content; composition that includes it; compound preparation procedure.
DK2748147T3 (en) Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
FI20116047L (en) Method for administering the health card
DK2872145T3 (en) CONDENSED BENZAZE PINS FOR THE TREATMENT OF TOURETE'S SYNDROME
TH129939B (en) Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL).